glp-1 and gip mechanism of action The dual glucose-dependent insulinotropic polypeptide (GIP) glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology GLP1 receptor agonist @nejm revisión

Glucagon-like peptide-1 receptor agonists and sodiumglucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: a systematic review and meta-analysis

Sirtuins are a family of enzymes that deacetylate proteins , removing acetyl groups from lysines on histones (which regulates gene expression) and on other proteins (which regulates metabolism and stress response)

Despite the relatively short half-life, clinical effects can persist for several hours to days after administration, suggesting that pharmacodynamic effects outlast plasma drug levels through persistent changes in neural circuit activity initiated by melanocortin receptor activation

Eur J Clin Nutr 68(5):541548

Measurable body composition changes, including decreased visceral fat and increased lean muscle, emerge around week 12

1UP Clear Protein closes the recovery gap efficiently, ensuring the physical foundation that supports both training adaptation and cognitive performance is being maintained daily